Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia

• DOI: 10.1007/s00277-024-06074-3
• Publication Date: 2024-11-07T02:03:02Z
• Authors: María Jazmín Toloza; Marco Lincango; María Fernanda Ca...; Martin Manuel Led...; Alicia Enrico; Beatriz Moiraghi; Fernanda Tosin; Romina Mariano; Mariel Pérez; Pedro Negri Arang...; María Elisa Riva; Irene B. Larripa; Carolina B. Belli